Found: 50
Select item for more details and to access through your institution.
The Intake of Dicarbonyls and Advanced Glycation Endproducts as Part of the Habitual Diet Is Not Associated with Intestinal Inflammation in Inflammatory Bowel Disease and Irritable Bowel Syndrome Patients.
- Published in:
- Nutrients, 2023, v. 15, n. 1, p. 83, doi. 10.3390/nu15010083
- By:
- Publication type:
- Article
Diet Quality and Dietary Inflammatory Index in Dutch Inflammatory Bowel Disease and Irritable Bowel Syndrome Patients.
- Published in:
- Nutrients, 2022, v. 14, n. 9, p. 1945, doi. 10.3390/nu14091945
- By:
- Publication type:
- Article
Modulation of Intestinal Epithelial Permeability by Plasma from Patients with Crohn's Disease in a Three-dimensional Cell Culture Model.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-018-38322-8
- By:
- Publication type:
- Article
Prediction of Inflammatory Bowel Disease Course Based on Fecal Scent.
- Published in:
- Sensors (14248220), 2022, v. 22, n. 6, p. 2316, doi. 10.3390/s22062316
- By:
- Publication type:
- Article
Anti-tumor necrosis factor therapy in patients with inflammatory bowel disease; comorbidity, not patient age, is a predictor of severe adverse events.
- Published in:
- International Journal of Colorectal Disease, 2020, v. 35, n. 12, p. 2331, doi. 10.1007/s00384-020-03716-6
- By:
- Publication type:
- Article
Probiotics in the Management of Inflammatory Bowel Disease: A Systematic Review of Intervention Studies in Adult Patients.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
De Nederlandse vertaling en indruksvalidatie van de ICECAP-A: meten van kwaliteit van leven volgens de capability-benadering.
- Published in:
- TSG: Tijdschrift Voor Gezondheidswetenschappen, 2016, v. 94, n. 8, p. 313, doi. 10.1007/s12508-016-0109-z
- By:
- Publication type:
- Article
Optimizing the Maastricht Work-Related Support intervention in clinical patient care: the value of integrating action research into intervention mapping.
- Published in:
- BMC Health Services Research, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12913-024-10752-3
- By:
- Publication type:
- Article
Systematic review: Patient‐related, microbial, surgical, and histopathological risk factors for endoscopic post‐operative recurrence in patients with Crohn's disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 3, p. 310, doi. 10.1111/apt.18040
- By:
- Publication type:
- Article
Letter: Intestinal permeability accounting for ongoing gastrointestinal symptoms following endoscopic remission in IBD—Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 12, p. 1646, doi. 10.1111/apt.18031
- By:
- Publication type:
- Article
Review article: A practical approach to persistent gastrointestinal symptoms in inflammatory bowel disease in remission.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 12, p. 1470, doi. 10.1111/apt.17988
- By:
- Publication type:
- Article
Effectiveness and safety of tofacitinib for ulcerative colitis: two‐year results of the ICC Registry.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 1, p. 117, doi. 10.1111/apt.17248
- By:
- Publication type:
- Article
Editorial: thiopurines in the multidrug era—time to rescue our memories over half a century of experience. Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 6, p. 1082, doi. 10.1111/apt.17186
- By:
- Publication type:
- Article
Classic drugs in the time of new drugs: real‐world, long‐term outcomes of thiopurine monotherapy in 1016 patients with inflammatory bowel disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 6, p. 1030, doi. 10.1111/apt.17128
- By:
- Publication type:
- Article
Systematic review with meta‐analysis: effect of inflammatory bowel disease therapy on lipid levels.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 54, n. 8, p. 999, doi. 10.1111/apt.16580
- By:
- Publication type:
- Article
Letter: tofacitinib in treatment‐refractory ulcerative colitis—a single centre real‐world experience in Australia. Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 54, n. 4, p. 534, doi. 10.1111/apt.16505
- By:
- Publication type:
- Article
Comorbidity, not patient age, is associated with impaired safety outcomes in vedolizumab‐ and ustekinumab‐treated patients with inflammatory bowel disease—a prospective multicentre cohort study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 8, p. 1366, doi. 10.1111/apt.16073
- By:
- Publication type:
- Article
Letter: effectiveness of ustekinumab or vedolizumab in Crohn's disease following anti‐TNF failure—getting closer to the truth. Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 7, p. 1255, doi. 10.1111/apt.16062
- By:
- Publication type:
- Article
Letter: ustekinumab's effectiveness compared with vedolizumab in Crohn's disease—what about mucosal healing and biomarkers? Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 4, p. 753, doi. 10.1111/apt.15959
- By:
- Publication type:
- Article
Ustekinumab is associated with superior effectiveness outcomes compared to vedolizumab in Crohn's disease patients with prior failure to anti‐TNF treatment.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 1, p. 123, doi. 10.1111/apt.15745
- By:
- Publication type:
- Article
A comparative analysis of tioguanine versus low‐dose thiopurines combined with allopurinol in inflammatory bowel disease patients.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 11, p. 1076, doi. 10.1111/apt.15730
- By:
- Publication type:
- Article
Off‐label prescriptions of drugs used for the treatment of Crohn's disease or ulcerative colitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 49, n. 10, p. 1293, doi. 10.1111/apt.15229
- By:
- Publication type:
- Article
Performance of Eight Infliximab Population Pharmacokinetic Models in a Cohort of Dutch Children with Inflammatory Bowel Disease.
- Published in:
- Clinical Pharmacokinetics, 2024, v. 63, n. 4, p. 529, doi. 10.1007/s40262-024-01354-7
- By:
- Publication type:
- Article
Fecal Microbial Composition of Ulcerative Colitis and Crohn’s Disease Patients in Remission and Subsequent Exacerbation.
- Published in:
- PLoS ONE, 2014, v. 9, n. 3, p. 1, doi. 10.1371/journal.pone.0090981
- By:
- Publication type:
- Article
The fecal microbiota as a biomarker for disease activity in Crohn's disease.
- Published in:
- Scientific Reports, 2016, p. 35216, doi. 10.1038/srep35216
- By:
- Publication type:
- Article
Exploring conditions for redistribution of anti‐tumor necrosis factors to reduce spillage: A study on the quality of anti‐tumor necrosis factor home storage.
- Published in:
- Journal of Gastroenterology & Hepatology, 2018, v. 33, n. 2, p. 426, doi. 10.1111/jgh.13920
- By:
- Publication type:
- Article
Defining Comprehensive Disease Control for Use as a Treatment Target for Ulcerative Colitis in Clinical Practice: International Delphi Consensus Recommendations.
- Published in:
- Journal of Crohn's & Colitis, 2024, v. 18, n. 1, p. 91, doi. 10.1093/ecco-jcc/jjad130
- By:
- Publication type:
- Article
Cost-Effectiveness Analysis of Increased Adalimumab Dose Intervals in Crohn's Disease Patients in Stable Remission: The Randomized Controlled LADI Trial.
- Published in:
- Journal of Crohn's & Colitis, 2023, v. 17, n. 11, p. 1771, doi. 10.1093/ecco-jcc/jjad101
- By:
- Publication type:
- Article
Ustekinuma b for Crohn's Disease: Two-Year Results of the Initiative on Crohn and Colitis (ICC) Registry, a Nationwide Prospective Observational Cohort Study.
- Published in:
- Journal of Crohn's & Colitis, 2021, v. 15, n. 11, p. 1920, doi. 10.1093/ecco-jcc/jjab081
- By:
- Publication type:
- Article
Anaplastic Large Cell T Cell Lymphoma in a Patient With Severe Therapy-refractory Crohn's Disease on Long-standing Immunosuppressive Medication During Ustekinumab Treatment: A Case Report and Review of the Literature.
- Published in:
- Journal of Crohn's & Colitis, 2019, v. 13, n. 11, p. 1470, doi. 10.1093/ecco-jcc/jjz084
- By:
- Publication type:
- Article
Corrigendum: Non-adherence to Anti-TNF Therapy is Associated with Illness Perceptions and Clinical Outcomes in Outpatients with Inflammatory Bowel Disease: Results from a Prospective Multicentre Study.
- Published in:
- Journal of Crohn's & Colitis, 2018, v. 12, n. 11, p. 1381, doi. 10.1093/ecco-jcc/jjy083
- By:
- Publication type:
- Article
Genomic and Expression Analyses Identify a Disease-Modifying Variant for Fibrostenotic Crohn's Disease.
- Published in:
- Journal of Crohn's & Colitis, 2018, v. 12, n. 5, p. 582, doi. 10.1093/ecco-jcc/jjy001
- By:
- Publication type:
- Article
A 20-Year Temporal Change Analysis in Incidence, Presenting Phenotype and Mortality, in the Dutch IBDSL Cohort--Can Diagnostic Factors Explain the Increase in IBD Incidence?
- Published in:
- Journal of Crohn's & Colitis, 2017, v. 11, n. 10, p. 1169, doi. 10.1093/ecco-jcc/jjx055
- By:
- Publication type:
- Article
Non-adherence to Anti-TNF Therapy is Associated with Illness Perceptions and Clinical Outcomes in Outpatients with Inflammatory Bowel Disease: Results from a Prospective Multicentre Study.
- Published in:
- Journal of Crohn's & Colitis, 2016, v. 10, n. 5, p. 549, doi. 10.1093/ecco-jcc/jjw002
- By:
- Publication type:
- Article
Comparison of Costs and Quality of Life in Ulcerative Colitis Patients with an Ileal Pouch-Anal Anastomosis, Ileostomy and Anti-TNFα Therapy.
- Published in:
- Journal of Crohn's & Colitis, 2015, v. 9, n. 11, p. 1016, doi. 10.1093/ecco-jcc/jjv134
- By:
- Publication type:
- Article
Disease Outcome of Ulcerative Colitis in an Era of Changing Treatment Strategies: Results from the Dutch Population-Based IBDSL Cohort.
- Published in:
- Journal of Crohn's & Colitis, 2015, v. 9, n. 10, p. 837, doi. 10.1093/ecco-jcc/jjv129
- By:
- Publication type:
- Article
Risk factors of work disability in patients with inflammatory bowel disease — A Dutch nationwide web-based survey: Work disability in inflammatory bowel disease.
- Published in:
- Journal of Crohn's & Colitis, 2014, v. 8, n. 7, p. 590, doi. 10.1016/j.crohns.2013.11.019
- By:
- Publication type:
- Article
Comment: Association Between Proton Pump Inhibitors and Microscopic Colitis: Implications for Practice and Future Research.
- Published in:
- 2017
- By:
- Publication type:
- letter
Low levels of IgM antibodies recognizing oxidation-specific epitopes are associated with human non-alcoholic fatty liver disease.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Impaired Gastric Cancer Survival in Patients with Inflammatory Bowel Disease.
- Published in:
- Journal of Gastrointestinal & Liver Diseases, 2016, v. 25, n. 4, p. 431, doi. 10.15403/jgld.2014.1121.254.nis
- By:
- Publication type:
- Article
Early infliximab trough levels in paediatric IBD patients predict sustained remission.
- Published in:
- Therapeutic Advances in Gastroenterology, 2023, p. 1, doi. 10.1177/17562848231222337
- By:
- Publication type:
- Article
Treatment of severe acute ulcerative colitis in SARS-CoV-2 infected patients: report of three cases and discussion of treatment options.
- Published in:
- Therapeutic Advances in Gastroenterology, 2021, v. 14, p. 1, doi. 10.1177/17562848211012595
- By:
- Publication type:
- Article
Treatment of severe acute ulcerative colitis in SARS-CoV-2 infected patients: report of three cases and discussion of treatment options.
- Published in:
- Therapeutic Advances in Gastroenterology, 2021, v. 14, p. 1, doi. 10.1177/17562848211012595
- By:
- Publication type:
- Article
Refining physical exercise training studies in patients with inflammatory bowel disease: patient selection and assessment of physical fitness changes.
- Published in:
- Trials, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s13063-024-08163-0
- By:
- Publication type:
- Article
Corticosteroid enhances epithelial barrier function in intestinal organoids derived from patients with Crohn's disease.
- Published in:
- Journal of Molecular Medicine, 2021, v. 99, n. 6, p. 805, doi. 10.1007/s00109-021-02045-7
- By:
- Publication type:
- Article
A Prediction Model for Successful Increase of Adalimumab Dose Intervals in Patients with Crohn's Disease: Secondary Analysis of the Pragmatic Open-Label Randomised Controlled Non-inferiority LADI Trial.
- Published in:
- Digestive Diseases & Sciences, 2024, v. 69, n. 6, p. 2165, doi. 10.1007/s10620-024-08410-z
- By:
- Publication type:
- Article
Ustekinumab Trough Concentrations Are Associated with Biochemical Outcomes in Patients with Crohn's Disease.
- Published in:
- Digestive Diseases & Sciences, 2023, v. 68, n. 6, p. 2647, doi. 10.1007/s10620-023-07822-7
- By:
- Publication type:
- Article
Switching From Reference Infliximab to Biosimilar CT-P13 Did Not Change Quality of Life in Stable Inflammatory Bowel Disease Patients.
- Published in:
- Crohn's & Colitis 360, 2022, v. 4, n. 3, p. 1, doi. 10.1093/crocol/otab001
- By:
- Publication type:
- Article
Pooled Resequencing of 122 Ulcerative Colitis Genes in a Large Dutch Cohort Suggests Population-Specific Associations of Rare Variants in MUC2.
- Published in:
- PLoS ONE, 2016, v. 11, n. 8, p. 1, doi. 10.1371/journal.pone.0159609
- By:
- Publication type:
- Article
The Effect of Sampling and Storage on the Fecal Microbiota Composition in Healthy and Diseased Subjects.
- Published in:
- PLoS ONE, 2015, v. 10, n. 5, p. 1, doi. 10.1371/journal.pone.0126685
- By:
- Publication type:
- Article